Ethics and Disclosure Sample Clauses

Ethics and Disclosure. I affirm the Author Representations noted below, and confirm that I have reviewed and complied with the relevant Instructions to Authors, Ethics in Publishing policy, and Conflicts of Interest disclosure. Please note that some journals may require that all co-authors sign and submit Conflicts of Interest disclosure forms. I am also aware of the publisher’s policies with respect to retractions and withdrawal. I am also aware of the publisher’s policies with respect to retractions and withdrawal and the journal home page. • The article I have submitted to the journal for review is original, has been written by the stated authors and has not been published elsewhere. • The article is not currently being considered for publication by any other journal and will not be submitted for such review while under review by this journal. • The article contains no libelous or other unlawful statements and does not contain any materials that violate any personal or proprietary rights of any other person or entity. • I have obtained written permission from copyright owners for any excerpts from copyrighted works that are included and have credited the sources in my article. • If I am using any personal details or images of patients or research subjects, I have obtained written permission or consent from the patient (or, where applicable, the next of kin). • If the article was prepared jointly with other authors, I have informed the co-author(s) of the terms of this publishing agreement and that I am signing on their behalf as their agent, and I am authorized to do so. DEFINITIONS Author’s version of the manuscript of an article that has been accepted for publication and which may include any author-incorporated changes suggested through the processes of submission processing, peer review, and editor-author communications. AAMs should not include other publisher value added contributions such as copy-editing, formatting and (if relevant) pagination, and should include the Appropriate Bibliographic Citation and a link to the final publication. Authors posting Accepted Author Manuscript online should later add a citation for the Published Journal Article indicating that the Article was subsequently published, and may mention the journal title provided they add the following text at the beginning of the document:
Sample 1Sample 2See All (6)
AutoNDA by SimpleDocs
Ethics and Disclosure. I affirm the Author Warranties noted below, and confirm that I have reviewed and complied with the relevant Instructions to Authors, the Ethics in Publishing policy, and Declarations of Interest disclosure. For further information see the IFAC web site, xxxxx://xxx.xxxx-xxxxxxx.xxx/.
Sample 1Sample 2
Ethics and Disclosure. I affirm the Author Representations noted below, and confirm that I have reviewed and complied with the relevant Instructions to Authors, CCLR Policy on Publication Ethics and Publication Malpractice Statement Ethics. I am also aware of the publisher's policies with respect to retractions and withdrawal
Sample 1
Ethics and Disclosure. If this Agreement includes services for attempting to influence government action, or any other form of lobbying, then the following are required. Please also see Section 5 of the Agreement Check If Applicable or indicate “N/A”: N/A Federal Lobbying: Contractor will timely provide Fxxxxx Mxx the amount of fees and services which are reportable as lobby activities under the Federal Lobby Disclosure Act. N/A State/Local Lobbying: Contractor will not engage in any state or local lobbying requiring registration or disclosure by Contractor or Fxxxxx Mxx under a state or local lobby law without such prior approval in a letter signed by Fannie Mae’s Business Point of Contact.
Sample 1
Ethics and Disclosure. (a) Fxxxxx Mxx adheres to the highest standards of ethical conduct and disclosure in its interaction with government. Fxxxxx Mxx requires Contractor to comply with all applicable lobby, gift, conflict of interest, ethics, and campaign contribution statutes, laws, and regulations and to avoid any appearance of impropriety. Contractor understands that failure to comply with such laws, and with the specific provisions of this section, may result in immediate termination of this Agreement, delayed payment by Fxxxxx Mxx or other sanctions. (b) Contractor agrees to comply with the following specific requirements in regard to direct or indirect lobbying of any government entity. (1) The Statement of Work must indicate if Contractor expects to lobby, register as a lobbyist, or engage in lobby activity on behalf of Fxxxxx Mxx. If Contractor expects to change its status in this regard, Contractor must provide an amended Statement of Work or Order Form to the Fxxxxx Mxx Business Point of Contact reflecting that change in status prior to engaging in lobbying on behalf of Fxxxxx Mxx. (2) Contractor shall respond in a timely manner to requests for information from Fannie Mae’s, Business Point of Contact as identified in accordance with Section 2, for the purpose of ensuring Fannie Mae’s compliance with applicable federal, state and local law, as well as conflict of interest laws, gift laws, tax laws, and laws pertaining to political contributions. Fxxxxx Mxx will similarly respond to any such requests from Contractor. (3) In regard to federal lobbying activity, Contractor shall provide to Fannie Mae’s Business Point of Contact an accounting of any and all fees and services to be disclosed by Fxxxxx Mxx under the Federal Lobby Disclosure Act on each monthly invoice, or in another mutually agreed upon manner in writing. (4) In regard to any state or local lobbying, Contractor shall obtain prior written approval from Fannie Mae’s Business Point of Contact prior to engaging in state or local lobbying on behalf of Fxxxxx Mxx, and further provide any information requested by Fxxxxx Mxx in questionnaires provided for the purpose of full and adequate disclosure of lobby activity. (5) Contractor shall, provide copies of any public filing disclosing the lobbying activities of Contractor on behalf of Fxxxxx Mxx. Any such document requiring an authorized signature by a representative of Fxxxxx Mxx shall be provided to Fannie Mae’s Business Point Contact for signature. (6) Contracto...
Sample 1
Ethics and Disclosure. If this Agreement includes services for attempting to influence government action, or any other form of lobbying, then the following are required. Please also see Section 5 of the Agreement Check If Applicable or indicate “N/A”: N/A Federal Lobbying: Contractor will timely provide Xxxxxx Xxx the amount of fees and services which are reportable as lobby activities under the Federal Lobby Disclosure Act. N/A State/Local Lobbying: Contractor will not engage in any state or local lobbying requiring registration or disclosure by Contractor or Xxxxxx Mae under a state or local lobby law without such prior approval in a letter signed by Xxxxxx Mae’s Business Point of Contact.
Sample 1
Ethics and Disclosure. I affirm the Author Representations noted below and confirm that I have reviewed and complied with the relevant Instructions to Authors, Ethics in Publishing policy, Declarations of Interest disclosure, and information for authors from countries affected by sanctions. Please note that some journals
Sample 1
AutoNDA by SimpleDocs
Ethics and Disclosure. 3.1 The Grant Recipient shall ensure that all use of Grant funds complies with the MedTech Europe Code of Ethical Business Practice and all applicable laws and legal regulations and industry codes of conduct. Particularly, where the Grant is provided to support Healthcare Professionals’ attendance at Third Party Organised Educational Events, the Grant Recipient shall ensure that the Grant is used in accordance with Chapter 1: General Criteria for Events, of MedTech Europe Code of Ethical Business Practice, including, but not limited to, the following principles: (a) Program akce: má přímo souviset s odborností nebo lékařskou praxí zdravotnického pracovníka účastnícího se akce nebo být natolik relevantní, aby jeho účast na akci opodstatnil; (a) The Event Programme: it should directly relate to the specialty and/or medical practice of the Healthcare Professional attending the event, or be sufficiently relevant to justify the Healthcare Professional’s attendance; (b) Lokace a místo konání akce: nemá být hlavní motivací Projektu; (b) Event Location and Venue: it should not become the main attraction of the Programme;
Sample 1

Related to Ethics and Disclosure

  • Use and Disclosure All Confidential Information of a party will be held in confidence by the other party with at least the same degree of care as such party protects its own confidential or proprietary information of like kind and import, but not less than a reasonable degree of care. Neither party will disclose in any manner Confidential Information of the other party in any form to any person or entity without the other party’s prior consent. However, each party may disclose relevant aspects of the other party’s Confidential Information to its officers, affiliates, agents, subcontractors and employees to the extent reasonably necessary to perform its duties and obligations under this Agreement and such disclosure is not prohibited by applicable law. Without limiting the foregoing, each party will implement physical and other security measures and controls designed to protect (a) the security and confidentiality of Confidential Information; (b) against any threats or hazards to the security and integrity of Confidential Information; and (c) against any unauthorized access to or use of Confidential Information. To the extent that a party delegates any duties and responsibilities under this Agreement to an agent or other subcontractor, the party ensures that such agent and subcontractor are contractually bound to confidentiality terms consistent with the terms of this Section 11.

  • Publicity and Disclosures No press releases or public disclosure, either written or oral, of the transactions contemplated by this Agreement, shall be made by a party to this Agreement without the prior knowledge and written consent of Buyer and the Company.

  • Use and Disclosure of PHI Business Associate is limited to the following permitted and required uses or disclosures of PHI: a. Duty to Protect PHI. Business Associate shall protect PHI from, and shall use appropriate safeguards, and comply with Subpart C of 45 CFR Part 164 (Security Standards for the Protection of Electronic Protected Health Information) with respect to EPHI, to prevent the unauthorized Use or disclosure of PHI other than as provided for in this Contract or as required by law, for as long as the PHI is within its possession and control, even after the termination or expiration of this Contract.

  • Confidentiality and Disclosure (a) The Agent and each Obligor agree to keep each Funding Rate confidential and not to disclose it to anyone, save to the extent permitted by paragraphs (b) and (c) below. (b) The Agent may disclose: (i) any Funding Rate to the Borrower pursuant to clause 8.7 (Notification of rates of interest); and (ii) any Funding Rate to any person appointed by it to provide administration services in respect of one or more of the Finance Documents to the extent necessary to enable such service provider to provide those services if the service provider to whom that information is to be given has entered into a confidentiality agreement substantially in the form of the LMA Master Confidentiality Undertaking for Use With Administration/Settlement Service Providers or such other form of confidentiality undertaking agreed between the Agent and the relevant Lender. (c) The Agent may disclose any Funding Rate and each Obligor may disclose any Funding Rate, to: (i) any of its Affiliates and any of its or their officers, directors, employees, professional advisers, auditors, partners and Representatives if any person to whom that Funding Rate is to be given pursuant to this paragraph (i) is informed in writing of its confidential nature and that it may be price-sensitive information except that there shall be no such requirement to so inform if the recipient is subject to professional obligations to maintain the confidentiality of that Funding Rate or is otherwise bound by requirements of confidentiality in relation to it; (ii) any person to whom information is required or requested to be disclosed by any court of competent jurisdiction or any governmental, banking, taxation or other regulatory authority or similar body, the rules of any relevant stock exchange or pursuant to any applicable law or regulation if the person to whom that Funding Rate is to be given is informed in writing of its confidential nature and that it may be price-sensitive information except that there shall be no requirement to so inform if, in the opinion of the Agent or the relevant Obligor, as the case may be, it is not practicable to do so in the circumstances; (iii) any person to whom information is required to be disclosed in connection with, and for the purposes of, any litigation, arbitration, administrative or other investigations, proceedings or disputes if the person to whom that Funding Rate is to be given is informed in writing of its confidential nature and that it may be price-sensitive information except that there shall be no requirement to so inform if, in the opinion of the Agent or the relevant Obligor, as the case may be, it is not practicable to do so in the circumstances; and (iv) any person with the consent of the relevant Lender.

  • Public Statements and Disclosure The parties hereto agree that the press release announcing the execution and delivery of this Agreement shall be in a form mutually agreed to by the Company and Parent and shall be issued as promptly as practicable following the execution of this Agreement. So long as this Agreement is in effect, neither the Company, on the one hand, nor Parent and Merger Sub, on the other hand, shall issue (or shall cause its Affiliates or Representatives to issue) any public release or make any public announcement concerning this Agreement or the transactions contemplated by this Agreement without the prior written consent of the other (which consent shall not be unreasonably withheld, conditioned or delayed), except as such release or announcement is required by applicable Law or the rules or regulations of NASDAQ or any other applicable stock exchange to which Parent is subject, in which case the party required to make the release or announcement shall use its reasonable best efforts to allow the other party or parties hereto a reasonable opportunity to comment on such release or announcement in advance of such issuance (it being understood that the final form and content of any such release or announcement, as well as the timing of any such release or announcement, shall be at the final discretion of the disclosing party); provided, however, that the restrictions set forth in this Section 7.4 shall not apply to any release or announcement made or proposed to be made by any party with respect to a Company Board Recommendation Change or to any “stop, look and listen” communication by the Company Board or any committee thereof to the Company Stockholders pursuant to Rule 14d-9(f) promulgated under the Exchange Act; provided, further, that the parties shall not be required by this Section 7.4 to provide such opportunity to comment to the other party in the event of any dispute between the parties relating to this Agreement. Notwithstanding the foregoing, (a) to the extent the content of any press release or other announcement has been approved and made in accordance with this Section 7.4, no separate approval shall be required in respect of such content to the extent replicated in whole or in part in any subsequent press release or other public announcement, and (b) each party may, without complying with the foregoing obligations, make any public statement regarding the transactions contemplated hereby in response to questions from the press, analysts, investors or those attending industry conferences, make internal announcements to employees and any documents, reports, statements forms or other filings required to be made by Parent or the Company with the SEC, in each case, to the extent that such statements substantially reiterate and are not inconsistent with previous press releases, public disclosures or public statements made jointly by the parties or approved by the parties, and otherwise in compliance with this Section 7.4.

  • Preservation and Disclosure of Lists The Trustee shall preserve, in as current a form as is reasonably practicable, all information as to the names and addresses of the Holders contained in the most recent list furnished to it as provided in Section 5.01 or maintained by the Trustee in its capacity as Note Registrar, if so acting. The Trustee may destroy any list furnished to it as provided in Section 5.01 upon receipt of a new list so furnished.

  • Press Releases and Disclosure The Company may issue a press release describing the material terms of the transactions contemplated hereby as soon as practicable following the date of this Agreement, and may file with the Commission a Current Report on Form 8-K, with this Agreement attached as an exhibit thereto, describing the material terms of the transactions contemplated hereby, and the Company shall consult with the Agent prior to making such disclosures, and the parties hereto shall use all commercially reasonable efforts, acting in good faith, to agree upon a text for such disclosures that is reasonably satisfactory to all parties hereto. No party hereto shall issue thereafter any press release or like public statement (including, without limitation, any disclosure required in reports filed with the Commission pursuant to the Exchange Act) related to this Agreement or any of the transactions contemplated hereby without the prior written approval of the other party hereto, except as may be necessary or appropriate in the reasonable opinion of the party seeking to make disclosure to comply with the requirements of applicable law or stock exchange rules. If any such press release or like public statement is so required, the party making such disclosure shall consult with the other party prior to making such disclosure, and the parties shall use all commercially reasonable efforts, acting in good faith, to agree upon a text for such disclosure that is reasonably satisfactory to all parties hereto.

  • Lead Disclosure If the property was built before 1978, the landlord must disclose whether or not there are known lead-based paint or lead-based paint hazards on the property. A “Disclosure of Information on Lead-Based Paint and/or Lead-Based Paint Hazards” is included at the end of this agreement for your reference. Step 21 – Enter Notices Information 30.

  • UPDATING AND DISCLOSING FINANCIAL INFORMATION You will provide facts

  • General Use and Disclosure Provisions Except as otherwise limited in this Section of the Contract, Business Associate may use or disclose PHI to perform functions, activities, or services for, or on behalf of, Covered Entity as specified in this Contract, provided that such use or disclosure would not violate the HIPAA Standards if done by Covered Entity or the minimum necessary policies and procedures of the Covered Entity.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!